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REM sleep behaviour disorder 
in patients 
without synucleinopathy
REM sleep behaviour disorder (RBD) is 
a parasomnia characterised by the loss 
of muscle atonia in REM sleep, leading 
to dream enactment behaviours with or 
without vocalisations. ‘Idiopathic’, or 
perhaps more accurately isolated, RBD 
occurs in the absence of an underlying 
neurological disorder and has a prevalence 
of 0.38% to 1.15% in the general popula-
tion aged over 60 years.1 2 It is recognised 
that RBD frequently represents an early 
prodromal marker of an emerging synu-
cleinopathy (Parkinson’s disease, dementia 
with Lewy bodies or multiple system 
atrophy), with over 70% of individuals 
developing one of these diseases over a 
12- year follow- up.3 However, RBD does 
not occur exclusively with synucleinopa-
thies. We set out to perform a systematic 
review to describe the spectrum of other 
neurological disorders associated with 
RBD.
We searched PubMed on 1st December 
2019 to identify all previous reports of 
polysomnography- confirmed RBD cases 
occurring in association with neurological 
conditions (online supplementary figure). 
The search terms ‘rapid eye movement 
sleep behaviour disorder’ OR ‘rapid eye 
movement sleep behavior disorder’ OR 
‘RBD’ were used. Only full- text articles 
published in the English language were 
considered. Pathological diagnoses were 
prioritised if this information was available; 
where mixed pathologies were reported, 
cases were excluded if one was a synu-
cleinopathy. Papers were excluded if the 
patients had been reported previously. Cases 
of subclinical RBD (defined as confirmed 
REM sleep without atonia in the absence 
of RBD symptoms), cognitive impairment 
or neurological presentations of uncertain 
aetiology, or RBD occurring in healthy indi-
viduals (usually children) were excluded. 
We did not include RBD cases associated 
with primary sleep disorders such as narco-
lepsy (which is known to be associated with 
RBD) or obstructive sleep apnoea (which 
can co- exist with RBD or directly lead 
to RBD- like movements during apnoeic 
episodes). RBD cases occurring while 
taking antidepressant medications were 
excluded, even if the patient had another 
neurological condition, since it remains 
unknown whether this reflects a reversible 
side effect or an unmasking of RBD in a 
patient subgroup that are at increased risk 
of developing a defined neurodegenerative 
syndrome. Although RBD has been associ-
ated with psychiatric disorders, these cases 
were excluded since they often occurred in 
the context of other neurological condi-
tions and/or antidepressants.
We found 237 patients with 
polysomnography- confirmed RBD 
occurring in association with neuro-
logical conditions not caused by alpha- 
synuclein pathology (table 1). Structural 
brain lesions, typically in the brainstem, 
accounted for 19% of cases (n=45). 
While ischaemic lesions were the predom-
inant aetiology, other lesions were also 
reported (eg, inflammatory, neoplastic, 
vascular malformations). The importance 
of the brainstem location, as opposed to 
the underlying disease mechanism, was 
further highlighted by co- occurrence of 
RBD and Arnold- Chiari malformations in 
29 patients (12%).
While RBD is typically regarded as an 
early feature of synucleinopathies, some 
patients had other degenerative brain 
diseases, specifically Alzheimer’s pathology 
(n=29, 12%) or tauopathy (n=22, 9%). 
We considered whether some of these 
cases may have been misdiagnosed synu-
cleinopathy cases, however several of them 
were pathological studies which makes this 
less likely. Autoimmune encephalitis was 
observed in 22 patients (9%), which is not 
surprising since these conditions are known 
to sometimes disrupt the sleep- wake state. 
Epilepsy (n=19, 8%), spinocerebellar 
ataxia (particularly SCA-3 (n=20, 8%)), 
traumatic brain injury (n=11, 5%) and 
Wilson’s disease (n=6, 3%) were among 
the other causes observed.
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Table 1 Non- synuclein pathologies associated with RBD
Condition Number of patients Subcategory Supplementary References
Structural brain lesion 45 Ischaemic (n=23)*, multiple sclerosis (n=7), indeterminate lesion (n=4), 
meningioma (n=3), adult- onset leukodystrophy (n=2), post- operative following 
brain surgery (n=1), brainstem cavernoma (n=1), aneurysm (n=1), brainstem 
lymphoma (n=1), astrocytoma (n=1), anoxic encephalopathy (n=1)
1,2, 3†, 4†,5,6, 7‡, 8-12, 13§, 14, 15, 
16¶, 17-21
Arnold- Chiari malformation 29 Type 1 (n=6), Type II (n=23) 22,23
Alzheimer’s disease 29 na 13§, 24-31, 32§
Spinocerebellar ataxia 25 SCA-3 (n=20), SCA of uncertain aetiology (n=4), SCA-31 (n=1) 30, 33-38
Autoimmune brain disease 22 Voltage- gated potassium channel antibody encephalitis (n=9), paediatric 
acute- onset neuropsychiatric syndrome (n=4), anti- Ma antibody encephalitis 
(n=3), encephalitis of uncertain aetiology (n=3), paraneoplastic cerebellar 
degeneration (n=2), NMDA receptor encephalitis (n=1)
6, 13§, 16¶, 39-42, 43§, 44, 45, 46
Epilepsy 19 na 15, 47-49
Progressive supranuclear palsy 15 na 6, 13§, 50, 51, 52§, 53
Traumatic brain injury 11 na 2, 3†, 54. 55
Guadeloupean parkinsonism** 7 na 51
Wilson’s disease 6 na 56, 57
This table highlights neurological conditions previously associated with polysomnography- confirmed RBD. Only conditions with five or more cases are shown, with the following 
conditions being observed less frequently: amyotrophic lateral sclerosis (n=4), dentatorubropallidoluysian atrophy (n=4), anti- IgLON5 disease (n=4), autism (n=4), Huntington’s 
disease (n=3), Creutzfeldt- Jakob disease (n=3), Mobius syndrome (n=2), Guillain- Barré syndrome (n=1), frontotemporal dementia (n=1), Tourette’s syndrome (n=1), myotonic 
dystrophy type 2 (n=1) and hereditary hyperekplexia (n=1).
*Mainly involving the pons.
†RBD occurred as part of parasomnia overlap syndrome.
‡Not located in the brainstem and one patient also had epilepsy.
§Pathologically confirmed cases.
¶Two patients did not undergo polysomnography but insufficient information from paper to confirm which ones.
**This is a form of tauopathy.
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Given the prevalence of RBD in the 
general population, we acknowledge that 
some of the reported associations may 
have been a coincidence and some of the 
patients might have gone on to develop a 
synucleinopathy over time. We also accept 
that there may be some misclassification 
of conditions that were diagnosed clin-
ically in the absence of histopathology. 
Furthermore, our search strategy may 
have underestimated the overall number 
of cases due to the inclusion of only 
polysomnography- confirmed RBD cases, 
as well as the number of RBD cases asso-
ciated with psychiatric conditions due to 
exclusion of these individuals (as a result 
of the potentially confounding influence 
of antidepressant medications).
Our findings indicate that a spectrum of 
neurological pathologies, many affecting 
the brainstem, can be associated with 
polysomnography- confirmed RBD, and 
these should be considered when the history 
or examination is not indicative of a synu-
cleinopathy. It seems likely that synucle-
inopathies lead to RBD by damaging these 
same brainstem regions as a result of them 
being particularly vulnerable to synuclein- 
mediated neurodegeneration. Normal 
REM sleep atonia is believed to be under 
the control of the subcoeruleus in the brain-
stem (which sends inhibitory projections 
to spinal motor neurons),4 with disrupted 
glutamate transmission in this region being 
particularly implicated in RBD.5
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